Contact Us
Databases
CrownLink
US Tel:
+1 858 622 2900
UK Tel:
+44 870 242 2900
All Contact Information
Our Services
Platforms
In Vitro
2D Cell Lines and Panels
2D Hu
Cell
™
CRISPR/Cas9
Organoids
High Content Imaging
In Vivo
PDX Models
CDX Models
Syngeneic Models
Humanized Models
Mi
Xeno
™
GEMMs
Mu
Prime
™
Orthotopics with Advanced Imaging
Human Biospecimens
Biomarkers and Bioanalysis
Data Science and Bioinformatics
Target Solutions
KRAS
EGFR
Drug Resistance
Patient Tissue
ADCs
Immuno-Oncology
Technologies
Bioinformatics
Preclinical Biomarker Discovery
Genomics Data Analysis
Protemoics Data Analysis
Mouse I/O RNA-Seq Panel
Cell Line Authentication with Deep Sequencing
CrownSyn
™
Biomarker Analysis
Biofluid Testing
Cytokine & Chemokine Profiling
Flow Cytometry
Rare Cell Analysis
Mass Spectrometry-based Proteomics
CRISPR/Cas9
Genomics
Standard Genomics Services
Next Generation Sequencing Services
Cell Line Authentication (CLA) with Deep Sequencing
Mouse I/O RNA-Seq Panel
NGS Data Analysis
In Vitro High Content Imaging
HCI
Mass Spectrometry-based Proteomics
Ex Vivo Patient Tissue
Spatial Multi-Omics Analysis
Service Types
Biomarker Discovery
PDX Mouse Clinical Trial
Biomarkers of Response: HuMark
™
Biomarker Discovery and Companion Diagnostics
Signatures of Response: HuSignature
™
DMPK Services
Efficacy Testing
Laboratory Services
Genomics and Transcriptomics
Proteomics Services
Spatial Biology and Digital Pathology
Immune Monitoring
Bioanalytical Services
Pharmacology & Bioanalytical Services
Biofluid Testing
Rodent Immuno-Safety Models
Safety Pharmacology Studies
Structural Biology
Target Validation
Screens
Omni
Screen
™
Mu
Screen
™
Organoid
Xplore
™
Toxicology
Consulting
Our Science
Scientific Publications
Resources
Blog
About Us
Our Company
Our Purpose
Our Responsibility
Leadership Team
Scientific Advisory Board
News & Events
Awards & Testimonials
Career Opportunities
Contact us
OcellO is now part of Crown Bioscience
Ocello has fully integrated into Crown Bioscience. We are now Crown Bioscience. Visit our new site to learn more about our expanded capabilities and services
Learn More
Share This
